USPTO serial 79082720
MEMOGAIN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 5, 2011
- Examiner
- HALMEN, KATHERINE E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEMOGAIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Galantos Pharma GmbH Biotechnikum Mainz
DE
Other trademarks owned by Galantos Pharma GmbH Biotechnikum Mainz
Galantos Pharma GmbH Biotechnikum Mainz
DE
Other trademarks owned by Galantos Pharma GmbH Biotechnikum Mainz
Galantos Pharma GmbH Biotechnikum Mainz
DE
Other trademarks owned by Galantos Pharma GmbH Biotechnikum Mainz
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ursula B. Day
708 Third AvenueSuite 1501New York, NY 10017Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations for the treatment of Alzheimer disease, dementia and Parkinson's disease; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system; veterinary preparations for treating diseases and disorders related to the central nervous system, alzheimer's disease the treatment of other dementias and parkinson's disease for domesticated animals, rats, mice and livestock; sanitary preparations for medical use; pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementia, and for the treatment of parkinson's disease, nootropics; pharmaceutical preparations for the treatment of schizophrenia, antidepressants, geriatric preparations, namely, pharmaceutical preparations and products for treating diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease; pharmaceutical preparations, namely, acetyloholinesterase inhibitors for the treatment of diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease; pharmaceutical preparations, namely, cholinergic enhancers for the treatment of diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease; pharmaceutical preparations, namely, cholinomimetics for the treatment of diseases and disorders of the central nervous system, for the treatment of alzheimer's disease, for the treatment of other dementias, and for the treatment of parkinson's disease | SECTION 71 - CANCELLED | — |
| 042 | Pharmaceutical research and development services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Galantos Pharma GmbH Biotechnikum Mainz
- Other trademarks owned by Galantos Pharma GmbH Biotechnikum Mainz
- Other trademarks owned by Galantos Pharma GmbH Biotechnikum Mainz
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MEMOGAIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2021 | UNDN | UNDELIVERABLE MAIL - NO ACTION TAKEN | — |
| May 1, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| May 1, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 14, 2018 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 18, 2018 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 18, 2018 | INPC | INVALIDATION PROCESSED | — |
| Oct 9, 2018 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 9, 2018 | C71T | CANCELLED SECTION 71 | — |
| Feb 20, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 4, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 25, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 6, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 6, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 5, 2011 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 5, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 19, 2011 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 19, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 30, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 30, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Mar 14, 2011 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 14, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2011 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 14, 2011 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2011 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2011 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 26, 2011 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 26, 2011 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 26, 2011 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 19, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 19, 2011 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 19, 2011 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2011 | ALIE | ASSIGNED TO LIE | — |
| Dec 27, 2010 | FAXX | FAX RECEIVED | — |
| Aug 28, 2010 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 28, 2010 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 28, 2010 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 28, 2010 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 27, 2010 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 23, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 11, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 10, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |